Sarah Sheldon, an engineering physicist from IBM, talks to Joe McEntee about the company’s efforts to open up the next ...

This important study demonstrates the potential of synthetic gene circuits to detect and target aberrant RAS activity in cancer cell lines. The circuit design is novel and the evidence supporting the ...